Home Exosome Theranostics

Exosome Theranostics

In operation
Series C
Molecular Diagnostic Testing Services Provider for Hematologic Cancers
Basic
Enterprise Profile

Basic Information

Exosome Diagnostics is developing molecular diagnostic tests based on biofluids for personalized medicine. Exosomes and other microvesicles enter all biofluids, including blood, urine, and cerebrospinal fluid, forming a highly enriched source of complete disease-specific nucleic acids. The company's proprietary exosome technology leverages this natural enrichment to enable high sensitivity and specificity for rare gene transcripts, as well as the expression of genes responsible for cancer and other diseases.
Exosome Diagnostics, Inc.
Massachusetts,United States of America
15~50 people
January 01, 2008
info@exosomedx.com

Enterprise Profile

Industrial Sector
Manufacture of Biological Pharmaceutical Products # Diagnostic Manufacturing
Technology
Liquid Biopsy Molecular Diagnostics
Concept
Hematology Department Tumor Laboratory Diagnosis
Application Scenarios
Medical Device Consumables